Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 441 participants.
Also called NCT01994889
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 441 participants
- Sponsor
- Registry
-
NCT01994889 -
2012-002465-35
-
- Other papers using this trial's data
- Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial
- Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])
- Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial
- Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Brazil, Canada, Czechia, France, Germany, Italy, Japan, Netherlands, Spain, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01994889. Randomized; quadruple masking; primary purpose treatment. Start 2013-12-09 (actual); primary completion 2018-02-07 (actual). Results posted on 2019-04-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
- Acronym
- ATTR-ACT
- Condition
- Transthyretin (TTR) Amyloid Cardiomyopathy
- Intervention (Drug)
- Tafamidis
- Intervention (Drug)
- Tafamidis
- Intervention (Drug)
- Placebo
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct01994889- Content hash
383789cd1d6556983c73bbf35b3e4c214f05ace447f73ff31f7021f8b6778d30